Clinical Trial Update: Monitoring Epstein-Barr Virus (EBV) Load in Rheumatoid Arthritis Patients Treated With New Immunosuppressive Drugs [NA]

View source ↗

Summary

This clinical trial update notes ongoing monitoring of Epstein-Barr virus load in rheumatoid arthritis patients treated with new immunosuppressive agents.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Undisclosed immunosuppressive agent(s) under study

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Rheumatoid Arthritis | NA | Status: UNKNOWN